BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
GATA1
,
Coagulation
,
Lung cancer
,
Adipose tissue
,
Biofuel
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PAR-1 receptor (1-41), human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is neces…
Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.
Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis.
Parstatin suppresses ocular neovascularization and inflammation.
Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) P…
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Anti…
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Perit…
Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresec…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ